Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model-Reference-Cited by-同舟云学术

Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model

Published:2010-04 Issue:7 Volume:79 Page:1007-1014
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Shevalye Hanna,Stavniichuk Roman,Xu Weizheng,Zhang Jie,Lupachyk Sergey,Maksimchyk Yury,Drel Viktor R.,Floyd Elizabeth Z.,Slusher Barbara,Obrosova Irina G.

Funder

Juvenile Diabetes Research Foundation International Grant

National Institutes of Health Grants

American Diabetes Association Grant

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference68 articles.

1. American Diabetes Association: nephropathy in diabetes;Molitch;Diabetes Care,2004

2. Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review;Strippoli;Brit Med J,2004

3. Kidney diseases in diabetes;Nelson,1995

4. Dyslipidaemia and cardiovascular disease in non-insulin-dependent diabetic patients with and without diabetic nephropathy;Parving;J Intern Med Suppl,1994

5. Subclinical atherosclerosis is increased in type 2 diabetic patients with microalbuminuria evaluated by intima-media thickness and pulse wave velocity;Yokoyama;Kidney Int,2004

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Poly(ADP-ribose) polymerase-1 affects vasopressin-mediated AQP2 expression in collecting duct cells of the kidney;American Journal of Physiology-Renal Physiology;2024-01-01

2. EDB-FN targeted probes for the surgical navigation, radionuclide imaging, and therapy of thyroid cancer;European Journal of Nuclear Medicine and Molecular Imaging;2023-02-18

3. EDB-FN targeted probes for the surgical navigation, radionuclide imaging and therapy of thyroid cancer;2023-01-03

4. D‑ribose: Potential clinical applications in congestive heart failure and diabetes, and its complications (Review);Experimental and Therapeutic Medicine;2021-03-17

5. ‘PARP’ing fibrosis: repurposing poly (ADP ribose) polymerase (PARP) inhibitors;Drug Discovery Today;2020-07